Resources for Alzheimer’s Prevention & Better Brain Health

At Altoida, we use digital biomarkers to radically change the method of assessing brain health and neurological diseases. After nearly two decades of research, we're developing a digital platform to measure and analyze biomarkers associated with neurocognitive impairment.

All
PUBLICATIONS
Press
mentions
Altoida Blog
Publications

Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer’s disease: the Altoida large cohort study

Read More

Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) (AltoidaML)

Read More

Digital biomarker-based individualized prognosis for people at risk of dementia

Read More

Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?

Read More
Press

Altoida Launches 5-Year Multi-Center Alzheimer’s Study with Eisai and Ionian University

Read More

Altoida Awarded FDA Breakthrough Designation for Development of World’s First Precision Neurology Device for Prediction of Alzheimer's Disease

Read More

Altoida Secures Funding and Research Partnership with Eisai Innovation to Accelerate Work Towards Predictive Dementia Diagnostics

Read More

Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases

Read More

Altoida Raises $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality

Read More
Mentions

Altoida's Alzheimer's-predicting smartphone app snags FDA breakthrough status

Read More

New Alzheimer’s Prediction Smartphone App Gets FDA Breakthrough Status

Read More

Altoida's Digital Neuro Signature and the future of population-level brain health management

Read More

EIT Award winner Altoida offers free remote brain health checks during COVID-19 pandemic

Read More

New funding for Alzheimer’s disease AR app developer Altoida

Read More

Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases

Read More

Altoida raises $6.3M to provide digital Alzheimer's biomarkers in augmented reality

Read More

Hope Biosciences Receives FDA Approval to Commence Groundbreaking Stem Cell Clinical Trial for Alzheimer’s Disease

Read More
Altoida Blog

The Gut-Brain Health Connection and Alzheimer's Disease Link Drives Future Therapeutic Approaches

READ MORE

Patients Ask: Can Healthy Living Prevent Alzheimer’s Disease?

READ MORE

8 Early Signs of Alzheimer’s Disease in Young Adults

READ MORE

Measurement Scales and Scoring Systems for Neurocognitive Assessments

READ MORE

Top Risk Factors for Neurodegenerative Disease

READ MORE

Taking a Look at Tau-Targeting Therapies for Alzheimer’s Disease

READ MORE

Patients Ask: What Are Digital Biomarkers and Why Are They Useful?

READ MORE

Utilizing Premorbid Functioning Assessment in Clinical Trials

READ MORE

Providing Baseline Testing For Younger Patients Paves the Way for Early Diagnosis

READ MORE

Patients Ask: What is Mixed Cortical and Subcortical Vascular Dementia?

READ MORE

The Importance of Computerized Cognitive Assessment and Care Plan Development for Newly Diagnosed Patients

READ MORE

Patients Ask: Is Dementia Hereditary?

READ MORE

Is Alzheimer’s The Most Common Form of Dementia?

READ MORE

Studies Find Connection Between Alzheimer’s and Parkinson’s Disease

READ MORE

What Do Digital Biomarkers Mean for Advancing Healthcare as a Whole?

READ MORE

Conducting Longitudinal Studies of Brain Health: Data Measurements and Analysis

READ MORE

Cognitive Function and Gut-Brain Health Relationship: Research That Cannot Be Ignored

READ MORE

Patients Ask: Does Early Diagnosis of Alzheimer’s Disease Enable More Effective Treatment?

READ MORE

Best Ways to Quantify Brain Health for Research Advancements

READ MORE

Patients Ask: Why Is Early Detection of Alzheimer’s Important?

READ MORE

Comprehensive Brain Testing for Dementia for Senior Care Facilities

READ MORE

Is There An Early Detection Test for Alzheimer’s?

READ MORE

The Best Foods That Support Brain Health, Memory, and Concentration

READ MORE

The Neuropathological Hallmarks of Alzheimer’s Disease

READ MORE

Effectively Communicating with Dementia Patients about Treatment Options

READ MORE

Digital Biomarkers for Alzheimer’s Disease: Early Diagnosis Means Early Treatment

READ MORE

Aducanumab: Alzheimer’s Disease Treatment Options & What This Means Moving Forward

READ MORE

Patients Ask: Is There a Blood Test for Alzheimer’s Genes?

READ MORE

Healthcare is Seeking a Reliable Brain Test App for Dementia

READ MORE

Exploring What Assessment Tools Are Used for Dementia Monitoring Following Diagnosis

READ MORE

Dispelling the Fear of Alzheimer’s Testing: Standardizing Cognitive Testing

READ MORE

Exploring The Relationship Between Artificial Intelligence and Brain Health

READ MORE

How to Prevent Alzheimer’s Disease Naturally

READ MORE

The Three Best Ways to Test Your Brain

READ MORE

Patients Ask: Can You Test Yourself for Dementia?

READ MORE

What Brain Health Assessment Test Is Best for Your Research Study or Clinical Trial?

READ MORE

Early-Onset Alzheimer’s Tests: A Guide to Available Testing Methods

READ MORE

Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer’s disease: the Altoida large cohort study

Read More

Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) (AltoidaML)

Read More

Digital biomarker-based individualized prognosis for people at risk of dementia

Read More

Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?

Read More

Altoida Launches 5-Year Multi-Center Alzheimer’s Study with Eisai and Ionian University

Read More

Altoida Awarded FDA Breakthrough Designation for Development of World’s First Precision Neurology Device for Prediction of Alzheimer's Disease

Read More

Altoida Secures Funding and Research Partnership with Eisai Innovation to Accelerate Work Towards Predictive Dementia Diagnostics

Read More

Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases

Read More

Altoida Raises $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality

Read More

Altoida's Alzheimer's-predicting smartphone app snags FDA breakthrough status

Read More

New Alzheimer’s Prediction Smartphone App Gets FDA Breakthrough Status

Read More

Altoida's Digital Neuro Signature and the future of population-level brain health management

Read More

EIT Award winner Altoida offers free remote brain health checks during COVID-19 pandemic

Read More

New funding for Alzheimer’s disease AR app developer Altoida

Read More

Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases

Read More

Altoida raises $6.3M to provide digital Alzheimer's biomarkers in augmented reality

Read More

Hope Biosciences Receives FDA Approval to Commence Groundbreaking Stem Cell Clinical Trial for Alzheimer’s Disease

Read More

The Gut-Brain Health Connection and Alzheimer's Disease Link Drives Future Therapeutic Approaches

READ MORE

Patients Ask: Can Healthy Living Prevent Alzheimer’s Disease?

READ MORE

8 Early Signs of Alzheimer’s Disease in Young Adults

READ MORE

Measurement Scales and Scoring Systems for Neurocognitive Assessments

READ MORE

Top Risk Factors for Neurodegenerative Disease

READ MORE

Taking a Look at Tau-Targeting Therapies for Alzheimer’s Disease

READ MORE

Patients Ask: What Are Digital Biomarkers and Why Are They Useful?

READ MORE

Utilizing Premorbid Functioning Assessment in Clinical Trials

READ MORE

Providing Baseline Testing For Younger Patients Paves the Way for Early Diagnosis

READ MORE

Patients Ask: What is Mixed Cortical and Subcortical Vascular Dementia?

READ MORE

The Importance of Computerized Cognitive Assessment and Care Plan Development for Newly Diagnosed Patients

READ MORE

Patients Ask: Is Dementia Hereditary?

READ MORE

Is Alzheimer’s The Most Common Form of Dementia?

READ MORE

Studies Find Connection Between Alzheimer’s and Parkinson’s Disease

READ MORE

What Do Digital Biomarkers Mean for Advancing Healthcare as a Whole?

READ MORE

Conducting Longitudinal Studies of Brain Health: Data Measurements and Analysis

READ MORE

Cognitive Function and Gut-Brain Health Relationship: Research That Cannot Be Ignored

READ MORE

Patients Ask: Does Early Diagnosis of Alzheimer’s Disease Enable More Effective Treatment?

READ MORE

Best Ways to Quantify Brain Health for Research Advancements

READ MORE

Patients Ask: Why Is Early Detection of Alzheimer’s Important?

READ MORE

Comprehensive Brain Testing for Dementia for Senior Care Facilities

READ MORE

Is There An Early Detection Test for Alzheimer’s?

READ MORE

The Best Foods That Support Brain Health, Memory, and Concentration

READ MORE

The Neuropathological Hallmarks of Alzheimer’s Disease

READ MORE

Effectively Communicating with Dementia Patients about Treatment Options

READ MORE

Digital Biomarkers for Alzheimer’s Disease: Early Diagnosis Means Early Treatment

READ MORE

Aducanumab: Alzheimer’s Disease Treatment Options & What This Means Moving Forward

READ MORE

Patients Ask: Is There a Blood Test for Alzheimer’s Genes?

READ MORE

Healthcare is Seeking a Reliable Brain Test App for Dementia

READ MORE

Exploring What Assessment Tools Are Used for Dementia Monitoring Following Diagnosis

READ MORE

Dispelling the Fear of Alzheimer’s Testing: Standardizing Cognitive Testing

READ MORE

Exploring The Relationship Between Artificial Intelligence and Brain Health

READ MORE

How to Prevent Alzheimer’s Disease Naturally

READ MORE

The Three Best Ways to Test Your Brain

READ MORE

Patients Ask: Can You Test Yourself for Dementia?

READ MORE

What Brain Health Assessment Test Is Best for Your Research Study or Clinical Trial?

READ MORE

Early-Onset Alzheimer’s Tests: A Guide to Available Testing Methods

READ MORE

Contact Us

80 M Street SE, Suite 100 Washington, DC 20003 USA 

CONTACT@ALTOIDA.COM

Follow Us

Policy

By visiting our Website and/or using the Services in any manner, you acknowledge that you accept the practices and policies outlined in our Privacy Policy.
@ Altoida 2021
chevron-down